FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fagron Vancomycin HCL IV bags recalled for sterility and port defect risk

OTHERPLASTICNationwide distribution

Stop using Fagron Vancomycin HCL IV bags

Fagron Compounding Services is recalling specific lots of Vancomycin HCL injections due to two safety concerns: the bags may not be sterile, and a blue plastic part on the administration port could detach during use. The recall affects over 11,600 bags distributed nationwide.

  • Check if your facility has any of the affected lot numbers (C274-000050987, C274-000049425, C274-000050069, C274-000050346, C274-000050698, C274-000050699, or C274-000050775)
  • Do not use affected bags; isolate and quarantine them immediately
  • Contact your pharmacy or supplier for replacement product
  • Report any use of recalled bags or adverse events to FDA MedWatch or Fagron
Hazard

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Sold states
Nationwide in the U.S.A.
Affected count
11,680 bags
Manufactured in
8710 E 34th St N, Wichita, KS, United States
Products
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0442-2026

More Fagron Compounding Services recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief